4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-101378
Director sold 154,900 shares at an average $44.87 ($6,950,453)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-08-26 | Sale 10b5-1 | −77,963 | $45.23 | $3,526,266 | 642,498 | I |
| Kersten Dirk Director | 2024-08-26 | Sale 10b5-1 | −11,534 | $45.79 | $528,142 | 630,964 | I |
| Kersten Dirk Director | 2024-08-27 | Sale 10b5-1 | −65,403 | $44.28 | $2,896,045 | 565,561 | I |
| Open-market sales · 154,900 sh · avg $44.87 · $6,950,453 | |||||||
Loading xslF345X05/ownership.xml…